Skip to main content

Advertisement

Log in

Hyperreflective foci in predicting the treatment outcome of antivascular endothelial growth factor in neovascular age-related macular degeneration

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To describe the optical coherence tomographic findings of hyperreflective foci (HF) in neovascular age-related macular degeneration and evaluate the use of HF to predict visual outcome after antivascular endothelium growth factor (anti-VEGF) therapy.

Methods

This was a post-hoc analysis of a retrospective cohort study. Hyperreflective foci were localized in the inner retina, outer retina, or subretinal fluid (SRF) layer. The treatment response of HF was recorded. The association between HF and visual outcome was analyzed.

Results

We enrolled 126 eyes. Hyperreflective foci involving more than one layer were associated with poor initial visual acuity (P < 0.001). Hyperreflective foci in each layer at baseline were negatively correlated with baseline visual acuity. At 3 months posttreatment, HF in the SRF layer had decreased significantly (P = 0.003), which was faster compared with HF in other layers. Baseline HF status at each layer was not associated with final visual outcome. The eyes with reduced HF in the SRF at 3 months had better visual improvement at 12 months (P = 0.038).

Conclusion

Hyperreflective foci involving multiple layers were associated with poor initial visual acuity but not with final visual outcome. With anti-VEGF treatment, HF in the SRF layer resolved faster, which may predict better visual outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bressler NM (2004) Age-related macular degeneration is the leading cause of blindness. JAMA 291:1900–1901

    Article  CAS  Google Scholar 

  2. Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364:1897–1908

    Article  CAS  Google Scholar 

  3. Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, Schmidt-Erfurth U (2012) VIEW 1 and VIEW 2 Study Groups. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119:2537–2548

    Article  Google Scholar 

  4. Schmidt-Erfurth U, Waldstein SM (2016) A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration. Prog Retin Eye Res 50:1–24

    Article  CAS  Google Scholar 

  5. Akagi-Kurashige Y, Tsujikawa A, Oishi A, Ooto S, Yamashiro K, Tamura H, Nakata I, Ueda-Arakawa N, Yoshimura N (2012) Relationship between retinal morphological findings and visual function in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 250:1129–1136

    Article  Google Scholar 

  6. Coscas G, De Benedetto U, Coscas F, Li Calzi CI, Vismara S, Roudot-Thoraval F, Bandello F, Souied E (2013) Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica 229:32–37

    Article  Google Scholar 

  7. Ho J, Witkin AJ, Liu J, Chen Y, Fujimoto JG, Schuman JS, Duker JS (2011) Documentation of intraretinal retinal pigment epithelium migration via high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology 118:687–693

    Article  Google Scholar 

  8. Pieroni CG, Witkin AJ, Ko TH, Fujimoto JG, Chan A, Schuman JS, Ishikawa H, Reichel E, Duker JS (2006) Ultrahigh resolution optical coherence tomography in non-exudative age-related macular degeneration. Br J Ophthalmol 90:191–197

    Article  CAS  Google Scholar 

  9. Bolz M, Schmidt-Erfurth U, Deak G, Mylonas G, Kriechbaum K, Scholda C (2009) Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology 116:914–920

    Article  Google Scholar 

  10. Christenbury JG, Folgar FA, O'Connell RV, Chiu SJ, Farsiu S, Toth CA (2013) Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci. Ophthalmology 120:1038–1045

    Article  Google Scholar 

  11. Karlstetter M, Scholz R, Rutar M, Wong WT, Provis JM, Langmann T (2015) Retinal microglia: just bystander or target for therapy? Prog Retin Eye Res 45:30–57

    Article  Google Scholar 

  12. Ma W, Zhao L, Wong WT (2012) Microglia in the outer retina and their relevance to pathogenesis of age-related macular degeneration. Adv Exp Med Biol 723:37–42

    Article  CAS  Google Scholar 

  13. Curcio CA, Zanzottera EC, Ach T, Balaratnasingam C, Freund KB (2017) Activated retinal pigment epithelium, an optical coherence tomography biomarker for progression in age-related macular degeneration. Invest Ophthalmol Vis Sci 58:Bio211-bio226.

  14. Lee H, Ji B, Chung H, Kim HC (2016) Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after anti-VEGF treatment in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Retina 36:465–475

    Article  CAS  Google Scholar 

  15. Lai TT, Hsieh YT, Yang CM, Ho TC, Yang CH (2019) Biomarkers of optical coherence tomography in evaluating the treatment outcomes of neovascular age-related macular degeneration: a real-world study. Sci Rep 9:529

    Article  Google Scholar 

  16. Segal O, Barayev E, Nemet AY, Geffen N, Vainer I, Mimouni M (2016) Prognostic value of hyperreflective foci in neovascular age-related macular degeneration treated with bevacizumab. Retina 36:2175–2182

    Article  CAS  Google Scholar 

  17. Kang JW, Chung H, Chan Kim H (2016) Correlation of optical coherence tomographic hyperreflective foci with visual outcomes in different patterns of diabetic macular oedema. Retina 36:1630–1639

    Article  Google Scholar 

  18. Nishijima K, Murakami T, Hirashima T, Uji A, Akagi T, Horii T, Ueda-Arakawa N, Muraoka Y, Yoshimura N (2014) Hyperreflective foci in outer retina predictive of photoreceptor damage and poor vision after vitrectomy for diabetic macular edema. Retina 34:732–740

    Article  Google Scholar 

  19. Uji A, Murakami T, Nishijima K, Akagi T, Horii T, Arakawa N, Muraoka Y, Ellabban AA, Yoshimura N (2012) Association between hyperreflective foci in the outer retina, status of photoreceptor layer, and visual acuity in diabetic macular edema. Am J Ophthalmol 153:710–717

    Article  Google Scholar 

  20. Mo B, Zhou HY, Jiao X, Zhang F (2017) Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion. Int J Ophthalmol 10:605–612

    PubMed  PubMed Central  Google Scholar 

  21. Ogino K, Murakami T, Tsujikawa A, Miyamoto K, Sakamoto A, Ota M, Yoshimura N (2012) Characteristics of optical coherence tomographic hyperreflective foci in retinal vein occlusion. Retina 32:77–85

    Article  Google Scholar 

  22. Lee H, Lee J, Chung H, Kim HC (2016) Baseline spectral domain optical coherence tomographic hyperreflective foci as a predictor of visual outcome and recurrence for central serous chorioretinopathy. Retina 36:1372–1380

    Article  CAS  Google Scholar 

  23. Kuroda M, Hirami Y, Hata M, Mandai M, Takahashi M, Kurimoto Y (2014) Intraretinal hyperreflective foci on spectral-domain optical coherence tomographic images of patients with retinitis pigmentosa. Clin Ophthalmol 8:435–440

    Article  Google Scholar 

  24. Folgar FA, Chow JH, Farsiu S, Wong WT, Schuman SG, O'Connell RV, Winter KP, Chew EY, Hwang TS, Srivastava SK, Harrington MW, Clemons TE, Toth CA (2012) Spatial correlation between hyperpigmentary changes on color fundus photography and hyperreflective foci on SDOCT in intermediate AMD. Invest Ophthalmol Vis Sci 53:4626–4633

    Article  Google Scholar 

  25. Miura M, Makita S, Sugiyama S, Hong YJ, Yasuno Y, Elsner AE, Tamiya S, Tsukahara R, Iwasaki T, Goto H (2017) Evaluation of intraretinal migration of retinal pigment epithelial cells in age-related macular degeneration using polarimetric imaging. Sci Rep 7:3150

    Article  Google Scholar 

  26. Framme C, Wolf S, Wolf-Schnurrbusch U (2010) Small dense particles in the retina observable by spectral-domain optical coherence tomography in age-related macular degeneration. Invest Ophthalmol Vis Sci 51:5965–5969

    Article  Google Scholar 

  27. Abri Aghdam K, Pielen A, Framme C, Junker B (2015) Correlation between hyperreflective foci and clinical outcomes in neovascular age-related macular degeneration after switching to aflibercept. Invest Ophthalmol Vis Sci 56:6448–6455

    Article  Google Scholar 

Download references

Funding

No funding was received for this research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tso-Ting Lai.

Ethics declarations

.

Conflict of interest

(1) The authors declare that they have no conflict of interest.

Ethical approval

(2) All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

(3) No Informed consent was obtained from the participants included in the study. Informed consent was not mandatory for this retrospective study

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hsia, Y., Yang, CH., Hsieh, YT. et al. Hyperreflective foci in predicting the treatment outcome of antivascular endothelial growth factor in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 258, 273–280 (2020). https://doi.org/10.1007/s00417-019-04546-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-019-04546-1

Keywords

Navigation